4.6 Article

Citalopram increases the differentiation efficacy of bone marrow mesenchymal stem cells into neuronal-like cells

Journal

NEURAL REGENERATION RESEARCH
Volume 9, Issue 8, Pages 845-850

Publisher

WOLTERS KLUWER MEDKNOW PUBLICATIONS
DOI: 10.4103/1673-5374.131601

Keywords

nerve regeneration; citalopram; stem cells; bone marrow mesenchymal stem cells; survival; proliferation; differentiation; neurons; neural regeneration

Funding

  1. Research Center for Science and Technology in Medicine (RCSTiM), Tehran University of Medical Sciences, Tehran (TUMS), Tehran, Iran

Ask authors/readers for more resources

Several studies have demonstrated that selective serotonin reuptake inhibitor antidepressants can promote neuronal cell proliferation and enhance neuroplasticity both in vitro and in vivo. It is hypothesized that citalopram, a selective serotonin reuptake inhibitor, can promote the neuronal differentiation of adult bone marrow mesenchymal stem cells. Citalopram strongly enhanced neuronal characteristics of the cells derived from bone marrow mesenchymal stem cells. The rate of cell death was decreased in citalopram-treated bone marrow mesenchymal stem cells than in control cells in neurobasal medium. In addition, the cumulative population doubling level of the citalopram-treated cells was significantly increased compared to that of control cells. Also BrdU incorporation was elevated in citalopram-treated cells. These findings suggest that citalopram can improve the neuronal-like cell differentiation of bone marrow mesenchymal stem cells by increasing cell proliferation and survival while maintaining their neuronal characteristics.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available